A new study suggests that an epilepsy drug could help alleviate symptoms of obstructive sleep apnoea, a common condition affecting about 5% of people. Presented at the European Respiratory Society Congress in Vienna, the research indicates that the drug sulthiame may significantly reduce breathing interruptions and improve oxygen levels during sleep. Obstructive sleep apnoea, which causes frequent interruptions in breathing during sleep, is often treated with mechanical devices like CPAP machines. However, many patients struggle with these devices, prompting the search for alternative treatments. The international study involved nearly 300 patients across Belgium, the Czech Republic, France, Germany, and Spain, who were either given sulthiame at varying doses or a placebo. After 12 weeks, those on sulthiame experienced up to 50% fewer breathing pauses and higher blood oxygen levels compared to those on the placebo. The most significant benefits were observed with the highest doses of the drug. Source: Oman News Agency
Related Articles
Three New E-Services Launched Via Oman Business Platform
Muscat: Acting in cooperation with Muscat Municipality, the Ministry of Commerce, Industry and Investment Promotion today launched the ‘Lease Contracts Service’ via Oman Business Platform. On the platform, the Ministry also launched the Financial Repo…
Israeli Occupation Strikes Al Nuseirat 63 Times Within Week, Killing 91
Muscat: The Israeli occupation has intensified its airstrikes and severe shelling on the Al Nuseirat refugee camp in central Gaza Strip in an unprecedented manner over the past seven days.
The Gaza government media office stated that the occupation f…
Tender Results of Government Treasury Bills Worth RO 176 Million Issued
Muscat: The total issuance of Government Treasury Bills amounted to RO 176.050 million. The value of the allotted Treasury bills amounted to RO 43.8 million, for a maturity period of 91 days. The average accepted price reached RO 98.980 for every RO 1…
